Captrust Financial Advisors Abbott Laboratories Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Captrust Financial Advisors holds 447,296 shares of ABT stock, worth $52.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

447,296

Previous 454,334 1.55%

Holding current value

$52.2 Million

Previous $51.6 Million 9.99%

% of portfolio

0.15%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $708,937 - $791,352	-7,038 Reduced 1.55%	447,296 $46.5 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.41 Million - $1.55 Million	12,847 Added 2.91%	454,334 $51.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $5.61 Million - $6.86 Million	62,168 Added 16.39%	441,487 $48.6 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.57 Million - $1.89 Million	16,470 Added 4.54%	379,319 $36.7 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.23 Million - $1.37 Million	12,220 Added 3.49%	362,849 $39.6 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $928,403 - $1.09 Million	9,585 Added 2.81%	350,629 $35.5 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $449,063 - $526,820	4,724 Added 1.4%	341,044 $37.5 Million
Q3 2022 Nov 16, 2022	BUY	$96.76 - $112.03 $1.23 Million - $1.43 Million	12,742 Added 3.94%	336,320 $32.5 Million
Q2 2022 Aug 23, 2022	BUY	$102.07 - $123.37 $32.9 Million - $39.8 Million	322,378 Added 26864.83%	323,578 $35.2 Million
Q2 2022 Aug 16, 2022	SELL	$102.07 - $123.37 $29.6 Million - $35.7 Million	-289,739 Reduced 99.59%	1,200 $130,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $1.5 Million - $1.83 Million	13,129 Added 4.73%	290,939 $34.4 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $259,595 - $317,860	2,247 Added 0.82%	277,810 $39.1 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $3.41 Million - $3.77 Million	29,240 Added 11.87%	275,563 $32.6 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.92 Million - $2.26 Million	18,184 Added 7.97%	246,323 $28.6 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $2.71 Million - $3.19 Million	24,915 Added 12.26%	228,139 $27.3 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $719,355 - $783,891	6,851 Added 3.49%	203,224 $22.3 Million
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $1.2 Million - $1.45 Million	-13,046 Reduced 6.23%	196,373 $21.3 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.68 Million - $2.15 Million	21,987 Added 11.73%	209,419 $19.2 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $3.66 Million - $5.35 Million	-58,201 Reduced 23.69%	187,432 $14.4 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $10.7 Million - $11.9 Million	136,563 Added 125.21%	245,633 $21.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $93,706 - $101,607	1,145 Added 1.06%	109,070 $9.13 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $3.35 Million - $3.91 Million	45,998 Added 74.28%	107,925 $9.08 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $94,760 - $114,565	1,431 Added 2.37%	61,927 $4.95 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $71,394 - $80,880	1,089 Added 1.83%	60,496 $4.38 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $1.35 Million - $1.63 Million	22,275 Added 59.99%	59,407 $4.36 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $127,920 - $141,185	2,222 Added 6.36%	37,132 $2.27 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $74,163 - $83,851	1,318 Added 3.92%	34,910 $2.03 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $1.58 Million - $1.69 Million	29,381 Added 697.72%	33,592 $1.92 Million
Q3 2017 Feb 16, 2018	BUY	$48.06 - $53.64 $202,380 - $225,878	4,211	4,211 $243,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.35B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $204B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Abbott Laboratories Transaction History